Q460N5 (PAR14_HUMAN) Homo sapiens (Human)

Protein mono-ADP-ribosyltransferase PARP14 UniProtKBInterProSTRINGInteractive Modelling

1801 aa; Sequence (Fasta) ; (Isoform 1; Isoform 3; Isoform 4; Isoform 5)

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5
5lxp
homo-2-mer1611-1801
2×7AG;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor MCD72
6g0w
homo-2-mer1613-1801
2×EGW;
Assess
Crystal structure of human poly(ADP-ribose) polymerase 14, catalytic domain in complex with an inhi…
4py4
homo-2-mer1613-1801
2×XL2;
Assess
Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphate
4d86
monomer791-1191
2×ADP;
Assess
Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphoribose
3vfq
monomer791-1191
1×AR6;
Assess
Human parp14 (artd8) - macro domain 2 in complex with adenosine-5-diphosphoribose
3q71
monomer999-1191
1×AR6;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H10
5lyh
monomer1612-1801
1×7B8;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK6
6fzm
monomer1612-1801
1×EE5;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitor
5nqe
monomer1612-1801
1×94Z;
Assess
PARP14 Macrodomain 2 with inhibitor
5o2d
monomer1002-1190
1×9HH;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with compound 3
6we3
monomer1613-1801
1×TZ7; 6×EDO; 1×PEG; 2×GOL; 3×SO4;
Assess
PARP14 catalytic domain in complex with OUL40
7r3l
monomer1613-1801
1×I1Q; 1×CL;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK1
6fym
monomer1613-1801
1×EBB;
Assess
Human poly(ADP-ribose) polymerase 14 (PARP14/ARTD8) - catalytic domain in complex with 6(5H)-phenan…
3se2
monomer1613-1801
1×LDR; 2×GOL;
Assess
crystal structure of PARP14 bound to N-{4-[4-(diphenylmethoxy)piperidin-1-yl]butyl}[1,2,4]triazolo[…
5v7t
monomer1613-1801
1×91V;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with RBN012759
6we2
monomer1613-1801
1×XBA; 1×EDO;
Assess
Human Artd8 (Parp14, Bal2) - catalytic domain in complex with A16(E)
4f1q
monomer1613-1801
1×0RZ;
Assess
Crystal structure of human poly(adp-ribose) polymerase 14, catalytic fragment in complex with an in…
3goy
monomer1613-1801
1×3AB;
Assess
Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a pyrimidine…
3smj
monomer1614-1801
1×FDR; 1×GOL;
Assess
Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7,8-tetrah…
5v7w
monomer1614-1801
1×91J;
Assess
Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z)
4f1l
monomer1615-1801
1×0RY; 1×NO3;
Assess
HUman PARP14 (ARTD8)-Macro domain 1 in complex with adenosine-5-diphosphoribose
3q6z
monomer792-978
1×APR;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with RBN012042
7l9y
monomer1615-1801
1×XRM; 2×CL; 1×EDO;
Assess
Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a quinazolin…
3smi
monomer1615-1801
1×QDR;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with compound 2
6we4
monomer1616-1801
1×FDR; 6×EDO;
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with RBN011980
7lun
monomer1616-1801
1×YFG;
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…
5qht
monomer1208-1388
2×CL; 1×DMS; 1×GQY;
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…
5qi9
monomer1208-1388
2×CL; 1×DMS; 1×GW1;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qi7
monomer1208-1388
2×CL; 1×DMS; 1×GVV;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qi0
monomer1208-1388
2×CL; 1×DMS; 1×GTJ;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qi3
monomer1208-1388
2×CL; 1×DMS; 1×GUY;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qi5
monomer1208-1388
2×CL; 1×DMS; 1×GV4;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qhu
monomer1208-1388
2×CL; 1×DMS; 1×9KS;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qi1
monomer1208-1388
2×CL; 1×DMS; 1×GUG;
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…
5qhv
monomer1208-1388
2×CL; 1×DMS; 1×AWP;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qi2
monomer1208-1388
2×CL; 1×DMS; 1×GUV;
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…
5qi8
monomer1208-1388
2×CL; 1×DMS; 1×GVY;
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…
5qi6
monomer1208-1388
2×CL; 1×DMS; 1×GV7;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qhx
monomer1208-1388
2×CL; 1×DMS; 1×GRY;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qhw
monomer1208-1388
2×CL; 1×DMS; 1×GRV;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qia
monomer1208-1388
2×CL; 1×DMS; 1×GWA;
Assess
HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3
4abl
monomer1208-1388
1×BR;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qhz
monomer1208-1388
2×CL; 2×DMS; 1×GT7;
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…
5qhy
monomer1208-1388
2×CL; 1×DMS; 1×GT4;
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…
5qi4
monomer1208-1388
2×CL; 1×DMS; 1×GV1;
Assess
HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3 IN COMPLEX WITH ADENOSINE- 5-DIPHOSPHORIBOSE
4abk
monomer1208-1388
1×AR6;
Assess
The Crystal Structure of human PARP14 from Biortus.
7d2c
monomer1208-1387
2×GOL; 2×CL;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5qhy.1.Amonomer0.901212-1387
1×GT4;100.00
Assess
3vfq.1.Amonomer0.86791-1191
1×AR6;100.00
Assess
5v7t.1.Amonomer0.731613-1801
100.00
Assess
8aly.1.Amonomer0.531553-1800
31.88
Assess

14 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 15qhy.1.Amonomer0.901131-1306
1×GT4;100.00
Assess
Isoform 13vfq.1.Amonomer0.86710-1110
1×AR6;100.00
Assess
Isoform 15v7t.1.Amonomer0.731532-1720
100.00
Assess
Isoform 18aly.1.Amonomer0.541472-1719
31.88
Assess
Isoform 35qhy.1.Amonomer0.90929-1104
1×GT4;100.00
Assess
Isoform 33vfq.1.Amonomer0.86508-908
1×AR6;100.00
Assess
Isoform 35v7t.1.Amonomer0.751330-1518
100.00
Assess
Isoform 38aly.1.Amonomer0.531270-1517
31.88
Assess
Isoform 45qhy.1.Amonomer0.901212-1387
1×GT4;100.00
Assess
Isoform 43vfq.1.Amonomer0.86791-1191
1×AR6;100.00
Assess
Isoform 55qhy.1.Amonomer0.91208-383
1×GT4;100.00
Assess
Isoform 53q71.1.Amonomer0.856-187
1×AR6;97.81
Assess
Isoform 57f41.1.Bmonomer0.79601-796
1×3AB;65.48
Assess
Isoform 58aly.1.Amonomer0.53549-796
32.31
Assess